The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Aurovisc OE
Hypromellose Ophthalmic Solution 2% w/v · HYPROMELLOSE 2208 (15000 MPA.S) 20 mg/mL · Solution · Ophthalmic · Aurolab
NDC 16030-0304-02 · 2 mL in 1 SYRINGE, GLASS · OTC MONOGRAPH DRUG · View full market →
Medicare Part D
Medicare Part D does not cover over-the-counter drugs — by law it pays only for products requiring a prescription.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Regulatory
- Application
- M018
- TE code
- —
- Approval date
- —
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Hypromellose Ophthalmic Solution 2% w/v (Solution)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Aurolab | HYPROMELLOSE 2208 (15000 MPA.S) 20 mg/mL | Jul 15, 2026 | Sep 3, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Aurovisc OE — NDC 16030-0304-02," retrieved September 3, 2026, https://drugdashboards.com/drug/16030030402.
Free to cite with attribution — see how the data is put together.